Review the whole routine
Acne can improve, worsen or change during pregnancy. Hormonal shifts can alter oil production and inflammation, while nausea, sensitivity and a changing skincare routine can affect tolerability. Severity still matters: a few comedones, widespread inflammatory acne and painful nodules do not need the same plan.
Bring every product—not just prescription medicine—to review. Retinoids can appear in night creams and combination acne products; acids and essential oils can be present under marketing names; supplements may contain high-dose vitamin A. “Natural,” “clean” and “topical” do not automatically mean suitable during pregnancy.
Oral isotretinoin is different
Oral isotretinoin is highly teratogenic and must not be used during pregnancy. The US FDA maintains a restricted risk-management program specifically to reduce embryo-fetal exposure. Thailand has its own prescribing and regulatory system, so US program steps should not be presented as Thai law—but the fetal risk is not geographically different.
If you become pregnant or think you may be pregnant while taking isotretinoin, stop taking it and contact the prescriber and your obstetric clinician promptly. Do not rely on an online risk calculator, make medication changes beyond the urgent instruction, or delay professional counselling because you feel embarrassed. Bring the medicine box, dose history and dates.
Topical retinoids and accidental exposure
Topical retinoids are absorbed much less than oral isotretinoin, but European regulators advise that topical retinoids should not be used during pregnancy or when planning pregnancy as a precaution. This includes active ingredients such as tretinoin, adapalene and tazarotene; brand names vary.
Observational studies and a meta-analysis have not shown a large increase in major adverse outcomes after inadvertent first-trimester topical exposure, but the evidence is not strong enough to justify continued use. If exposure happened, stop the product and discuss the exact ingredient, amount, body area and dates with your clinician. Accidental exposure is a reason for informed review—not panic or self-directed conclusions.
How doctors weigh topical options
A doctor may consider ingredients with lower systemic exposure and more reassuring product information, while matching treatment to acne type and keeping the routine simple. For example, a current US azelaic-acid label states that systemic absorption after topical use is minimal and maternal use is not expected to cause fetal exposure. That is useful product information, not a blanket instruction that every azelaic product, concentration or use is right for every pregnancy.
Clinicians also consider irritation, body surface area, broken skin, other medicines, allergy and whether an antibiotic is truly needed. Antibiotic monotherapy can contribute to resistance; oral and topical antibiotics are not interchangeable, and choices can depend on pregnancy stage. This article intentionally does not provide a medication list or dosing plan.
A gentle cleanser, non-comedogenic moisturiser and broad-spectrum sun protection may support the skin barrier and reduce the visibility of post-acne pigment, but “basic” products still need an ingredient check if sensitivity or allergy is present.
Peels, lasers and clinic procedures
A clinic procedure does not bypass pregnancy evidence gaps. Chemical peels differ by acid, concentration, treated area and absorption. Light and laser devices differ by wavelength and indication; numbing products and aftercare medicines add separate exposure questions. Injectable fillers, botulinum toxin, biostimulators and PN/PDRN products do not have adequate controlled pregnancy safety evidence for elective cosmetic use.
For a non-urgent cosmetic concern, postponing a procedure until after pregnancy is often the clearest way to avoid uncertain exposure. If a procedure is being considered for a medical reason, the dermatologist and obstetric clinician should weigh the specific indication and alternatives together. Do not accept “the energy stays only in the skin” as a complete safety assessment.
How to prepare for a consultation
- List gestational stage and relevant pregnancy complications
- Photograph every skincare, medicine and supplement label
- Note when acne changed and whether lesions are painful or scarring
- Record allergy, eczema, asthma and previous drug-reaction history
- State current obstetric medicines and any fertility treatment
- Ask what evidence supports each ingredient in this formulation and treated area
- Ask which symptoms should trigger earlier review
Choose a licensed doctor rather than relying on a salesperson to screen pregnancy risk. Our clinic and doctor verification guide shows where to check.
Do not rush scar treatment
Active inflammatory acne is usually controlled before elective scar procedures. New lesions can create new scars, while pregnancy-related pigment changes and skin sensitivity can complicate how treatment response is judged. Flat red or brown marks are not the same as depressed scars; see our acne-scar guide.
A short delay in elective resurfacing is not “losing the window.” A stable diagnosis and safe medication plan matter more than starting a package while hormones, products and tolerance are changing.
Why “safe” is not one label
Pregnant people are usually excluded from cosmetic trials, so absence of reported harm is often not proof of safety. Regulatory labels may rely on systemic absorption, animal data, inadvertent human exposures and pharmacology. Guidance also changes. Always check the current label for the exact product and use local medical advice rather than copying a list across countries.
Breastfeeding is a separate assessment. A product avoided in pregnancy is not automatically avoided for the same reason during breastfeeding, and a pregnancy-compatible option is not automatically appropriate on or near the breast.
The bottom line
During pregnancy, review the entire acne routine and elective procedure plan. Oral isotretinoin must not be used; topical retinoids are avoided as a precaution. Other ingredients require product-specific, pregnancy-stage-specific assessment rather than a universal “safe” stamp. Work with a dermatologist and obstetric clinician, and choose control of active acne over rushing into scar or cosmetic procedures.